Home Tags Thyme Care

Thyme Care

Thyme Care, the leading value-based cancer care enabler, announced the close of a $95M capital raise. With $55M in equity funding, Thyme Care welcomes new investor Concord Health Partners with participation from all existing investors, including CVS Health® Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, and Foresite Capital. Banc of California will provide an additional $40M in debt financing, bringing Thyme Care’s total amount raised to date to $178M.

[Funding News] Thyme Care Secures $95M Series C Funding To Fuel Cancer...

Team SR -
© Copyright Startup Rise USA 2026 All Rights Reserved.